Coats Group Earnings Calls
| Release date | Mar 05, 2026 |
| EPS estimate | $0.0473 |
| EPS actual | $0.0488 |
| EPS Surprise | 3.17% |
| Revenue estimate | 770M |
| Revenue actual | 757M |
| Revenue Surprise | -1.69% |
| Release date | Jul 31, 2025 |
| EPS estimate | $0.0451 |
| EPS actual | $0.0366 |
| EPS Surprise | -18.73% |
| Revenue estimate | 708.167M |
| Revenue actual | 705.4M |
| Revenue Surprise | -0.391% |
| Release date | Jul 30, 2025 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
| Release date | Mar 06, 2025 |
| EPS estimate | $0.0352 |
| EPS actual | $0.0256 |
| EPS Surprise | -27.19% |
| Revenue estimate | 728M |
| Revenue actual | 736.817M |
| Revenue Surprise | 1.21% |
Last 4 Quarters for Coats Group
Below you can see how CGGGF performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Mar 06, 2025 |
| Price on release | $1.13 |
| EPS estimate | $0.0352 |
| EPS actual | $0.0256 |
| EPS surprise | -27.19% |
| Date | Price |
|---|---|
| Feb 28, 2025 | $1.13 |
| Mar 03, 2025 | $1.13 |
| Mar 04, 2025 | $1.13 |
| Mar 05, 2025 | $1.13 |
| Mar 06, 2025 | $1.13 |
| Mar 07, 2025 | $1.13 |
| Mar 10, 2025 | $1.13 |
| Mar 11, 2025 | $1.13 |
| Mar 12, 2025 | $1.13 |
| 4 days before | 0% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 0% |
| Release date | Jul 30, 2025 |
| Price on release | $1.03 |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Jul 24, 2025 | $1.05 |
| Jul 25, 2025 | $1.05 |
| Jul 28, 2025 | $1.05 |
| Jul 29, 2025 | $1.05 |
| Jul 30, 2025 | $1.03 |
| Jul 31, 2025 | $1.03 |
| Aug 01, 2025 | $1.03 |
| Aug 04, 2025 | $1.02 |
| Aug 05, 2025 | $0.98 |
| 4 days before | -2.14% |
| 4 days after | -4.85% |
| On release day | 0% |
| Change in period | -6.89% |
| Release date | Jul 31, 2025 |
| Price on release | $1.03 |
| EPS estimate | $0.0451 |
| EPS actual | $0.0366 |
| EPS surprise | -18.73% |
| Date | Price |
|---|---|
| Jul 25, 2025 | $1.05 |
| Jul 28, 2025 | $1.05 |
| Jul 29, 2025 | $1.05 |
| Jul 30, 2025 | $1.03 |
| Jul 31, 2025 | $1.03 |
| Aug 01, 2025 | $1.03 |
| Aug 04, 2025 | $1.02 |
| Aug 05, 2025 | $0.98 |
| Aug 06, 2025 | $0.98 |
| 4 days before | -1.44% |
| 4 days after | -5.06% |
| On release day | 0% |
| Change in period | -6.43% |
| Release date | Mar 05, 2026 |
| Price on release | $1.20 |
| EPS estimate | $0.0473 |
| EPS actual | $0.0488 |
| EPS surprise | 3.17% |
| Date | Price |
|---|---|
| Feb 27, 2026 | $1.24 |
| Mar 02, 2026 | $1.21 |
| Mar 03, 2026 | $1.20 |
| Mar 04, 2026 | $1.20 |
| Mar 05, 2026 | $1.20 |
| Mar 06, 2026 | $1.20 |
| Mar 09, 2026 | $1.15 |
| Mar 10, 2026 | $1.19 |
| Mar 11, 2026 | $1.19 |
| 4 days before | -2.99% |
| 4 days after | -0.83% |
| On release day | 0% |
| Change in period | -3.80% |
Coats Group Earnings Call Transcript Summary of Q4 2025
Key points for investors: Coats delivered a resilient 2025 despite a softer end‑market backdrop. Organic revenue was broadly flat (CER) while the group outperformed its apparel and footwear markets and gained share. EBIT was $290m and group operating margin expanded 80bp to 19.8%. Free cash flow (pre-dividends) reached a record $160m and year‑end net debt (ex leases) implied pro‑forma leverage of 2.2x after the OrthoLite acquisition; management expects leverage to fall below 2.0x by end‑2026. Strategic portfolio moves included the acquisition of OrthoLite (EV $770m) and the divestment of the U.S. Yarns business, improving portfolio quality and adding higher‑margin, cash‑generative capacity. Management upgraded medium‑term targets: revenue CAGR >5% through the cycle, group margin target raised to 21–23%, and cumulative free cash flow over the next five years increased from $750m to $1bn (now defined after exceptionals). Target adjacencies (Safety Fabrics, energy tapes, Coats Digital, ProWeave, lifestyle trims) contributed ~ $45m sales in 2025 and added ~1 percentage point to group growth; OrthoLite integration carries $20m of identified synergies by 2028 (c.$5m in 2026). Sustainability remains a differentiator (EcoVerde recycled thread scale, Scope 1&2 reductions, zero waste to landfill). Capital allocation: disciplined capex ($32m in 2025; guide $40–45m including OrthoLite), progressive dividend (FY dividend up 5%), continued focus on deleveraging, organic growth and selective M&A / buybacks. Main near‑term risk noted: potential disruption from the Middle East conflict, which management is monitoring.
Sign In
Buy CGGGF